MedTrace Logo

Brain Metastases in Norway - A Prospective Cohort Study

NCT03346655 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2023-11-03

No results posted yet for this study

Summary

The overall aim and primary outcome of this study will be a descriptive analysis of the current treatment practice of BM in Norway. Specifically, it may give answers to the following research questions:

* What is the true incidence of BM in Norway?
* How are patients with BM treated at present?
* Do treatments differ between hospitals?
* How do treatments impact quality of life of the patients?
* Which factors (treatment, tumor and host variables) can explain disease control, survival, symptom relief, and general functions?
* How can BM staging be improved?

Conditions

Sponsors & Collaborators

  • Norwegian Cancer Society

    collaborator OTHER

  • South-Eastern Norway Regional Health Authority

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Olav E Yri, MD · Post-doc

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2022-03-31
Completion
2024-11-01

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03346655 on ClinicalTrials.gov